LAS VEGAS—Insurer-mandated barriers to care for patients with inflammatory bowel disease were associated with decreased satisfaction with insurance and adverse clinical outcomes, including increased odds of IBD-related surgery and corticosteroid rescue, according to results of a study presented at the 2024 Crohn’s & Colitis Congress.
“These data illustrate the negative impacts of insurer-mandated medication barriers on patients with IBD,” said